Neurogene
$18.94
0
-$4.06-17.65% Tuesday 07:06
Statistics
Day High
19.63
Day Low
18.94
52W High
-
52W Low
-
Volume
8
Avg. Volume
-
Mkt Cap
293.38M
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
8MayExpected
Expected EPS
-1.354286
Actual EPS
N/A
Financials
-8,123.68%Profit Margin
Unprofitable1.85MRevenue
-150.29MNet Income
Analyst Ratings
$106.67Average Price Target
The highest estimate is 200.00.
From 3 ratings within the last 6 months. This is not an investment recommendation.
From 3 ratings within the last 6 months. This is not an investment recommendation.
Buy 100%
Hold 0%
Sell 0%
People Also Follow
This list is based on the watchlists of people on Stock Events who follow NGNE.BOATS. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
Neurogene Inc. develops life-changing genetic medicines for patients and their families affected by neurological diseases. Its product candidate includes NGN-401, an investigational AAV9 gene therapy for the treatment of Rett syndrome; and NGN-101 to treat neuronal ceroid lipofuscinosis subtype 5 batten disease. The company is headquartered in New York, New York.
Show more...
CEO
ISIN
US64135M1053
Listings
0 Comments
Share your thoughts
FAQ
What is Neurogene stock price today?▼
The current price of NGNE.BOATS is $18.94 USD — it has decreased by -17.65% in the past 24 hours. Watch Neurogene stock price performance more closely on the chart.
What is Neurogene stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Neurogene stocks are traded under the ticker NGNE.BOATS.
What is Neurogene market cap?▼
Today Neurogene has the market capitalization of 293.38M
When is the next Neurogene earnings date?▼
Neurogene is going to release the next earnings report on May 08, 2026.
What were Neurogene earnings last quarter?▼
NGNE.BOATS earnings for the last quarter are -0.99 USD per share, whereas the estimation was -1.25 USD resulting in a +20.76% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Neurogene revenue for the last year?▼
Neurogene revenue for the last year amounts to 1.85M USD.
What is Neurogene net income for the last year?▼
NGNE.BOATS net income for the last year is -150.29M USD.
When did Neurogene complete a stock split?▼
Neurogene has not had any recent stock splits.